Vitamin E does not regress hypercholesterolemic atherosclerosis

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 14, Issue 3, 2009, Pages 231-241

  Prasad, Kailash ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Antioxidants; Aortic chemiluminescence; Lipoproteins; Regression of atherosclerosis; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DIET; FEMALE; HYPERCHOLESTEROLEMIA; LEUKOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HYPERCHOLESTEROLEMIA; LEUKOCYTES; LIPIDS; MALONDIALDEHYDE; OXIDATIVE STRESS; RABBITS; REACTIVE OXYGEN SPECIES; TIME FACTORS; VITAMIN E;

EID: 69949097491     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248409337003     Document Type: Article

References (44)

1. Prasad K., Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J. 1993 ; 125 (4). 958-973.
2. Prasad K., Kalra J., Lee P. Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: effects of Probucol. Int J Angiol. 1994 ; 3 (1). 100-112.
3. Steinberg D. Antioxidants in the prevention of human atherosclerosis. Circulation. 1992 ; 85 (6). 2337-2344.
4. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation. 1999 ; 99 (10). 1355-1362.
5. Prasad K., Lee P. Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. Atherosclerosis. 2007 ; 192 (2). 313-322.
6. Knekt P., Reunanen A., Järvinen R., Seppänen R., Heliövaara M., Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 1994 ; 139 (12). 1180-1189.
7. Rimm EB, Stampfer MJ, Ascherio A., Giovannucci E., Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993 ; 328 (20). 1450-1456.
8. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B., Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993 ; 328 (20). 1444-1449. (Pubitemid 23143846)
9. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y., Bostick RM Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996 ; 334 (18). 1156-1162.
10. Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med. 2002 ; 251 (5). 372-392.
11. Stephens NG, Parsons A., Schofield PM, Kelly F., Cheeseman K., Mitchinson MJ Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996 ; 347 (9004). 781-786.
12. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Population for Epidemiologic Studies of the Elderly. Am J Clin Nutr. 1996 ; 64 (2). 190-196.
13. Salonen JT, Nyyssönen K., Salonen R., et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med. 2000 ; 248 (5). 377-386.
14. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999 ; 354 (9177). 447-455.
15. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 ; 360 (9326). 23-33.
16. de Gaetano G. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet. 2001 ; 357 (9250). 89-95.
17. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000 ; 342 (3). 154-160. (Pubitemid 30051646)
18. Weinberg RB, VanderWerken BS, Anderson RA, Stegner JE, Thomas MJ Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet. Arterioscler Thromb Vasc Biol. 2001 ; 21 (6). 1029-1033.
19. Cheung MC, Zhao XQ, Chait A., Albers JJ, Brown BG Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol. 2001 ; 21 (8). 1320-1326.
20. Kapoor R., Prasad K. Role of oxyradicals in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion: effect of SOD and catalase. Circ Shock. 1994 ; 43 (2). 79-94.
21. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissue by thoibarbituric acid reaction. Anal Biochem. 1979 ; 95 (2). 351-358.
22. Lee P. Prasad K. Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by cyclooxygenase inhibitors. Int J Angiol. 2003 ; 12 (1). 13-23. (Pubitemid 37153422)
23. Gornall AG, Bardawill CJ, David MM Determination of serum proteins by means of biuret reaction. J Biol Chem. 1949 ; 177 (2). 751-766.
24. Holman RL, McGill Jr HC, Strong JP, Geer JC Techniques for studying atherosclerotic lesions. Lab Invest. 1958 ; 7 (1). 42-47.
25. Prasad K. Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Atherosclerosis. 2008 ; 197 (1). 34-42.
26. Kesaniemi YA, Grundy SM Lack of effect of tocopherol on plasma lipids and lipoproteins in man. Am J Clin Nutr. 1982 ; 36 (2). 224-228.
27. Sun YP, Zhu BQ, Sievers RE, Norkus EP, Parmley WW, Deedwania PC Effects of antioxidant vitamins C and E on atherosclerosis in lipid-fed rabbits. Cardiology. 1998 ; 89 (3). 189-194.
28. Yoshida N., Murase H., Kunieda T., et al. Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits. Atherosclerosis. 2002 ; 162 (1). 111-117.
29. Ismail NM, Abdul Ghafar N., Jaarin K., Khine JH, Top GM Vitamin E and factors affecting atherosclerosis in rabbits fed a cholesterol-rich diet. Int J Food Sci Nutr. 2000 ; 51 (suppl): S79 - S94.
30. Komaratat P., Chupukcharoen N., Wilairat P. Effect of vitamin E on cholesterol plasma lipoprotein distribution and metabolism in rabbit. Int J Vitam Nutr Res. 1985 ; 55 (2). 167-171.
31. Viswanathan NM, Bhakthran NMG, Rockarhis RA Effect of dietary supplementation of vitamin E on serum lipids and lipoproteins in rabbits fed a cholesterolemic diet. Int J Vitam Nutr Res. 1979 ; 49 (4). 370-375.
32. Chen MF, Hsu HC, Liau CS, Lee YT The role of vitamin E on the anti-atherosclerotic effect of fish oil in diet-induced hypercholesterolemic rabbits. Prostaglandins Other Lipid Mediat. 1999 ; 57 (2-3). 99-111.
33. Packer JE, Slater TF, Willson RL Direct observation of a free radical interaction between vitamin E and vitamin C. Nature. 1979 ; 278 (5706). 737-738.
34. Metz S., Riedm?üller K., Kinscherf R., Metz J. Possibilities of regression in arteriosclerosis. Z Gerentol Geriatr. 2001 ; 34 (6). 466-469.
35. Prasad K. A study on regression of hypercholesterolemic atherosclerosis in rabbits by flax lignan complex. J Cardiovasc Pharmacol Ther. 2007 ; 12 (4). 304-313.
36. Hiebert LM, Liu J. Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites. Atherosclerosis. 1990 ; 83 (1). 47-51.
37. Martin A., Foxall T., Blumberg JB, Meydani M. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscler Thromb Vasc Biol. 1997 ; 17 (3). 429-436.
38. Chiu JJ, Wung BS, Shyy JY, Hsieh HJ, Wang DL Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol. 1997 ; 17 (12). 3570-3577.
39. Zhu BQ, Sievers RE, Sun YP, Isenberg WM, Parmley WW Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits. J Cardiovasc Pharmacol. 1992 ; 19 (2). 246-255.
40. Willingham AK, Bolanos C., Bohannan E., Cenedella RJ The effects of high levels of vitamin E on the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. J Nutr Biochem. 1993 ; 4 (11). 651-654.
41. Burton GW, Ingold KU Vitamin E.: applications of the principles of physical organic chemistry to the explanation of its structure and function. Acc Chem Res. 1986 ; 19 (7). 194-201.
42. Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J. 1992 ; 288 (pt 2). 341-344.
43. Doba T., Burton GW, Ingold KU Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. Biochim Biophys Acta. 1985 ; 835 (2). 298-303.
44. Mantha SV, Prasad M., Kalra J., Prasad K. Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. Atherosclerosis. 1993 ; 101 (2). 135-144.